What is microscopic polyangiitis (MPA)?
MPA is a rare autoimmune disease. The immune system inflames small blood vessels, which can injure the organs those vessels feed.
Every medical claim on this page links to its source. Last updated 15 November 2026. Educational information, not medical advice.
The short version
- "Vasculitis" means inflamed blood vessels. In MPA the inflammation is in small vessels.1
- The kidneys are often involved. Inflamed filters can let blood and protein leak into urine, and kidney function can drop, sometimes quickly. Lungs, nerves and skin can also be affected.2,1
- MPA is one of three related diseases called ANCA-associated vasculitis (AAV).2
- Treatment usually aims to calm the inflammation first (induction), then keep it quiet (maintenance). There is no proven cure, but MPA can stay quiet for years.2
What is ANCA?
ANCA are antibodies aimed at proteins inside a type of white blood cell. Most people with MPA have a type called MPO-ANCA. Some have PR3-ANCA, and some test negative. Activated white blood cells and part of the immune system called complement help cause the vessel injury.2,3
What causes it?
In most people the trigger is unknown. Researchers study genetic susceptibility and environmental factors, but genes do not give a reliable personal prediction, and MPA does not follow a simple single-gene inheritance pattern.4,5 Some medicines, including hydralazine and propylthiouracil, can cause a similar illness, which is one reason your team reviews your medication list.2
How common is it?
MPA is rare. Estimates vary by country and by how studies define cases, so we do not quote a single number here.5
For researchers and clinicians
MPA is classified within AAV; KDIGO 2024 and the 2025 BSR recommendations frame management by ANCA specificity and organ involvement rather than by clinical label alone. MPO and PR3 disease differ in genetic associations; clinical diagnosis and antibody category can overlap.2,3,4
Next: What the diagnosis means · Your first 30 days
Sources
- Vasculitis Foundation: Microscopic polyangiitis (MPA) [doc ref 7]
- KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
- Rheumatology (2025): 2025 British Society for Rheumatology recommendations for ANCA-associated vasculitis [doc ref 40]
- EBioMedicine (2026): Exploration of the genetic architecture of ANCA-associated vasculitis [doc ref 33]
- Orphanet: Microscopic polyangiitis [doc ref 34]
Links checked 15 November 2026. Full list: all sources.